MELISSA BLAIR: Open Payments
NPI 1821248717 · SEVIERVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,660 in 74 payments from 17 companies in 2025. Trend: 2023 $519 · 2024 $1,425 · 2025 $1,660
Food & beverage: $1,643Education: $17
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 11 | $271 |
| Axsome Therapeutics, Inc. | 9 | $207 |
| Insmed, Inc. | 6 | $160 |
| Viatris Specialty LLC | 8 | $139 |
| GlaxoSmithKline, LLC. | 7 | $130 |
| Amgen Inc. | 5 | $98 |
| AstraZeneca Pharmaceuticals LP | 5 | $96 |
| Philips North America LLC | 5 | $88 |
| Regeneron Healthcare Solutions, Inc. | 3 | $75 |
| United Therapeutics Corporation | 3 | $69 |
Products named: DUPIXENT, Sunosi, Arikayce, YUPELRI, TEZSPIRE, NUCALA, Vest Therapy Und, Tyvaso.
Industry payments across TN — which companies pay providers there.
